MegaRobo Technologies raises nearly $200 million in round including Oman's sovereign wealth fund
Bloomberg reports the Chinese biotech firm uses AI and robotics to speed up drug research, and that investors are increasingly backing such companies.
What happened
MegaRobo Technologies is a Chinese biotech company. It has raised nearly $200 million from investors. One of them is Oman's sovereign wealth fund, a state-owned pool of money that invests for the country.
Why it matters to you
The deal shows that investors are putting real money into companies that use AI and robots to find new medicines faster.
The takeaway
Money is flowing into AI and robotics firms that aim to speed up drug research.
What it means for you
The funding points to continued demand for teams that combine AI software with lab robotics for drug research.
Drug developers weighing AI and automation partners can see that investors are backing the sector, per Bloomberg.
Bloomberg reports a nearly $200 million round that included Oman's sovereign wealth fund, and says investors are piling into AI and robotics drug research firms.